The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations Gabriel PardoDavid E. Jones Review Open access 06 September 2017 Pages: 2351 - 2374
Correction to: The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations Gabriel PardoDavid E. Jones Correction 23 October 2017 Pages: 2375 - 2377
Suicidality is a common and serious feature of anti-N-methyl-D-aspartate receptor encephalitis Le ZhangJosemir W. SanderDong Zhou Original Communication 09 October 2017 Pages: 2378 - 2386
A novel mutation of VAPB in one Chinese familial amyotrophic lateral sclerosis pedigree and its clinical characteristics Yi-min SunYi DongJian-jun Wu Original Communication 09 October 2017 Pages: 2387 - 2393
Treatment outcome in patients with clinically defined carpal tunnel syndrome but normal electrodiagnostic test results: a randomized controlled trial Floriaan G. C. M. De KleermaekerJan MeulsteeWim I. M. Verhagen Original Communication 09 October 2017 Pages: 2394 - 2400
The natural history of depressive symptoms in patients with incident Parkinson’s disease: a prospective cohort study Jan Petter LarsenIngvild DalenOle-Bjørn Tysnes Original Communication 14 October 2017 Pages: 2401 - 2408
Natalizumab therapy is associated with changes in serum JC virus antibody indices over time John PetersEric Williamson Original Communication 16 October 2017 Pages: 2409 - 2412
Prevalence and clinical characteristics of cortical superficial siderosis in patients with acute stroke Satoshi SudaTakashi ShimoyamaKazumi Kimura Original Communication 23 October 2017 Pages: 2413 - 2419
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study Sara MariottoSergio FerrariAlberto Gajofatto Original Communication Open access 23 October 2017 Pages: 2420 - 2430
Characterization of Charcot–Marie–Tooth optic neuropathy Benjamin BotsfordLaurel N. VuongCarlos E. Mendoza-Santiesteban Original Communication 23 October 2017 Pages: 2431 - 2435
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing–remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study) Giancarlo ComiFrancesco PattiFor the Golden Study Group Original Communication Open access 23 October 2017 Pages: 2436 - 2449
Clinical implications of CT hyperdense artery sign in patients with acute middle cerebral artery occlusion in the era of modern mechanical thrombectomy Seul Kee KimByung Hyun BaekWoong Yoon Original Communication 26 October 2017 Pages: 2450 - 2456
An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington’s disease Benjamin R. UnderwoodZeyn W. Green-ThompsonRoger A. Barker Original Communication Open access 26 October 2017 Pages: 2457 - 2463
Characterisation of pain in people with hereditary neuropathy with liability to pressure palsy Darren BealesRobyn FaryTim Mitchell Original Communication 27 October 2017 Pages: 2464 - 2471
Assessing the influence of age and gender on the phenotype of myotonic dystrophy type 2 Federica MontagneseStefania MondelloBenedikt Schoser Original Communication 30 October 2017 Pages: 2472 - 2480
Quality of life predictors in patients with chronic inflammatory demyelinating polyradiculoneuropathy Ivo BozovicAleksandra KacarIvana Basta Original Communication 30 October 2017 Pages: 2481 - 2486
Reversible amygdala enlargement: a longitudinal observation of a patient with elderly onset temporal lobe epilepsy Takashi MatsudairaYoshio OmoteYushi Inoue Letter to the Editors 24 October 2017 Pages: 2487 - 2490
Disease reactivation after switching from natalizumab to daclizumab Timo UphausChristoph OberwittlerStefan Bittner Short Commentary 03 October 2017 Pages: 2491 - 2494
Can developmental venous anomalies cause seizures? Claire DussaulePascal MasnouChristian Denier Neurological Update 17 March 2017 Pages: 2495 - 2505
Cannabidiol as a treatment for epilepsy William O. PickrellNeil P. Robertson Journal club Open access 09 November 2017 Pages: 2506 - 2508
Maksymilian Rose (1883–1937) Katarzyna Pekacka-FalkowskaMichal K. OweckiAnna Maria Pekacka Pioneers in Neurology Open access 18 August 2017 Pages: 2509 - 2510